Thumbnail Image
Publication

NIMRAD - A Phase III trial to investigate the use of Nimorazole hypoxia modification with Intensity-modulated radiotherapy in head and neck cancer.

Thomson, David J
; 
Yang, H
; 
Baines, H
; 
Miles, E
; 
Bolton, S
; 
West, Catharine M L
; 
Slevin, Nicholas J
Citations
Altmetric:
Abstract
Authors
Thomson, David J
Yang, H
Baines, H
Miles, E
Bolton, S
West, Catharine M L
Slevin, Nicholas J
Affiliation
Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
Description
Date
2014-03-27
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Citation
NIMRAD - A phase III trial to investigate the use of Nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer. 2014: Clin Oncol
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/315919
Embedded videos